A. B. Walker

Differential vasoactive effects of the insulin sensitizers rosiglitazone (BRL 49653) and troglitazone on human small arteries in vitro.

G. Williams, R. Buckingham, E. Naderali, 1998, Diabetes.

Impaired insulin-induced attenuation of noradrenaline-mediated vasoconstriction in insulin-resistant obese Zucker rats.

G. Williams, R. Buckingham, M. Savage, 1997, Clinical science.

Vascular reactivity to noradrenaline and neuropeptide Y in the streptozotocin‐induced diabetic rat

E. Masson, G. Williams, C. Bodmer, 1995, European journal of clinical investigation.

The thiazolidinedione rosiglitazone (BRL-49653) lowers blood pressure and protects against impairment of endothelial function in Zucker fatty rats.

G. Williams, R. Buckingham, P. Chattington, 1999, Diabetes.

Insulin-induced attenuation of noradrenaline-mediated vasoconstriction in resistance arteries from Wistar rats is nitric oxide dependent.

G. Williams, M. Savage, J. Dores, 1997, Clinical science.

Hypogonadotrophic hypogonadism and primary amenorrhoea associated with increased melatonin secretion from a cystic pineal lesion

J. Arendt, J. English, I. MacFarlane, 1996, Clinical endocrinology.

Comparable vasorelaxant effects of 17α- and 17β-oestradiol on rat mesenteric resistance arteries: an action independent of the oestrogen receptor

E. Naderali, Gareth H. Williams, P. Doyle, 1999 .